Results 21 to 30 of about 53,534 (265)
Drug-eluting stent thrombosis [PDF]
, 2009 Drug-eluting stents (DES) have reduced the risk of repeat revascularization procedures by 50-70% compared with bare metal stents across a wide range of lesion and patients subsets.
Pilgrim, T, Windecker, S
core +2 more sources
Heart Views, 2011 Very late stent thrombosis occurs more frequently with drug-eluting stents and tends to occur despite dual antiplatelet therapy or after long periods of clopidogrel discontinuation.
Prashanth Panduranga +1 more
doaj +1 more source
Coincidental Occurrence of Acute In-stent Thrombosis and Iatrogenic Vessel Perforation During a Wingspan Stent Placement: Management with a Stent In-stent Technique [PDF]
Neurointervention, 2012 We presented a case that an acute in-stent thrombosis after the deployment of a Wingspan stent was successfully managed with a stent in-stent technique.
Sun Joo Lee +3 more
doaj +1 more source
The Role of Dual Antiplatelet in Stent-Assisted Coiling in Wide-Neck Aneurysm
Aksona, 2023 Highlight: • Dual antiplatelet is the gold standard for endovascular treatment of wide-neck aneurysms. • The role of dual antiplatelet is to prevent stent thrombosis after treatment.
Ricky Gusanto Kurniawan +3 more
doaj +1 more source
Medicinski pregled, 2009 Introduction. Late stent thrombosis is a serious complication after stent Implantation and it can lead to the development of acute myocardial infarction or death. A case report. A 43-year-old patient was admitted to our clinic to coronary care unit. He was diagnosed with acute ST elevation myocardial reinfarction of inferoposterior localisation and ...
Milovan, Petrović +5 more
openaire +3 more sources
Case Reports in Medicine, 2009 Although safety profiles of sirolimus-eluting stents do not seem to differ in short-to-medium term from those of bare-metal stents, late stent thrombosis after deployment of drug-eluting stents has emerged as a potential safety concern in the era of high-
Dirk Sibbing +3 more
doaj +1 more source
Quality of anticoagulant therapy and the incidence of in‐stent thrombosis after venous stenting
Research and Practice in Thrombosis and Haemostasis, 2020 Background In patients with a venous outflow obstruction following iliofemoral deep vein thrombosis stenting of the venous tract to prevent or alleviate postthrombotic syndrome is applied with increasing frequency.
Pascale Notten +6 more
doaj +1 more source
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. [PDF]
, 2009 BACKGROUND: There is no consensus regarding the safety and efficacy of drug-eluting stents, as compared with bare-metal stents, in patients with ST-segment elevation myocardial infarction who are undergoing primary percutaneous coronary intervention (PCI)
Brodie, Bruce R. +23 more
core +1 more source
Reactive thrombocytosis leading to stent thrombosis
Journal of the Practice of Cardiovascular Sciences, 2020 Percutaneous coronary intervention is associated with many complications, and stent thrombosis is the most feared among them. Common etiologies of stent thrombosis include high angiographic thrombus burden, inadequate antiplatelet dosing, total stent ...
Piyush Kalantri +4 more
doaj +1 more source
“The unpredictable ABSORB” – very late stent thrombosis of bioresorbable vascular scaffold
Heart Views, 2019 Bioresorbable vascular scaffolds represent the next revolution in stent technology. They serve the dual purpose of antiproliferative drug delivery to vascular lumen like a drug-eluting stents (DES) as well as phased strut resorption over time leading to ...
Akshyaya Pradhan +3 more
doaj +1 more source